However, no study has provided in-depth insight explaining if the transition from decreased Treg in the NASH stage toward increased Treg in the HCC site is regulated by the tumor cell or is an event that could appear in the NASH condition in response to high CD8 T cell activity and fibrosis/cirrhosis. This evidence concerns the gene CD8A and hepatocellular carcinoma.